Texas Alzheimer’s Research and Care Consortium

Texas Alzheimer’s Research and Care Consortium
Texas Alzheimer’s Research and Care Consortium2021-06-21T09:45:19-05:00

The Texas Alzheimer’s Research and Care Consortium (TARCC) is a collaboration between ten of the state’s leading medical research institutions, working to improve early diagnosis, treatment, and prevention of Alzheimer’s disease.

The Texas Council on Alzheimer’s Disease and Related Disorders has provided $52,471,321.23 in research grants since 2005.

2005-2021 Disbursements by Site:

Baylor College of Medicine$6,529,703.93 (2005-2021)

The University of Texas Southwestern Medical Center$16,868,466.20 (2005-2021)

The University of North Texas Health Science Center$9,402,049.88 (2005-2021)

Texas Tech University Health Sciences Center$5,542,118.97 (2005-2021)

The University of Texas Health Science Center at San Antonio

$6,306,330.15 (2009-2021)

Texas A&M Health Science Center

$2,789,085.50 (2014-2021)

The University of Texas at Austin$1,718,023.60 (2016-2021)

The University of Texas Health Science Center at Houston

$1,954,261.20 (2005-2009; 2018-2021)

UTMB Health (Galveston)

$750,000.00 (2018-2021)

UT Rio Grande Valley

$611,281.80 (2019-2021)

Grand Total: $52,471,321.23

TARCC Funding Distributions since 2005

Alzheimer's Facts

brain-icon-small-11 in 9 people age 65+ has Alzheimer's disease.

brain-icon-small-1About 490,000 Texans are projected to have Alzheimer's by 2025.

brain-icon-small-11 in 3 seniors dies with Alzheimer's disease or another dementia.

brain-icon-small-1Every 66 seconds, someone in the United States develops Alzheimer’s.

Get Involved

TARCC 2022 Scientific Symposium

Advances in Alzheimer’s Disease Science, Research, and Care

Save the date!
January 26-27, 2022

Read more about this free event here.

Texas Alzheimer’s Research and Care Consortium Scientific Symposium

TARCC Research Updates

TARCC investigators have been involved in a number of new, important research studies. Recently published research is wide ranging, spanning the gamut from clinical trials to new cognitive diagnostics; blood-based biomarkers in Mexican-Americans;  identification of additional risk genes; and validation of biomarker algorithms in AD patients and AD animal models.

View all TARCC researcher publications here.
View all TARCC Investigator Grant Awards here.

Beakers illustration

Read TARCC's Latest Facebook Posts:

Texas Alzheimer's Research and Care Consortium

1 week 2 days ago

TARCC investigator, Bharti Manwani at UT Health Houston, examines the influence of gender on build-up of proteins in brain blood vessels, a major contributor to impaired cognition and stroke. www.sciencedirect.com/science/article/pii/S2666354621000636

Texas Alzheimer's Research and Care Consortium

1 week 5 days ago

Contributing to an important national genetics consortium study, TARCC samples were used to examine the involvement of mitochondrial dysfunction in AD-related brain pathology.alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.12396

Texas Alzheimer's Research and Care Consortium

1 month 16 hours ago

TARCC investigator Dr. Gladys Maestre will testify in an open hearing for the U.S. House of Representatives addressing the global health care gaps in terms of Alzheimer’s disease diagnosis and treatment. Livestream the hearing at 9am CST on Friday June 25th. Click link here: foreignaffairs.house.gov/2021/6/brain-health-a-global-perspective